# McLeod Alpha Research Report: 2026-04-16 Trading Room

## Scope and Evidence

External qualitative research based on the authorized DayTradeSPY April 16, 2026 recording page (post 44434). The authorized Vimeo Transcript control was reviewed. This document retains synthesized evidence only, not source transcript content.

## Observations

- The source described a trend-line hold beneath a clearly identified resistance area, treating the hold as constructive but not equivalent to clearing the resistance.
- Later, price rolled over at a 50 EMA and reached a Fibonacci-extension area; the room responded by locating support rather than assuming the extension would reverse.
- Near the end of the reviewed discussion, a one-minute doji followed a downside move and was followed by a green recovery bar; the source used this sequence as an example of intraday indecision and reversal context.
- The recording also described extended periods of one-minute indecision, which favors an observation of short-horizon uncertainty rather than a durable directional conclusion.
- No specific option contract, bid/ask sequence, position size, or realized result was retained, so execution and option risk cannot be inferred from the structural commentary.

## Research Implications

1. Test `TRENDLINE_HOLD_UNDER_RESISTANCE` as a two-stage candidate: measure the hold, then require acceptance through resistance; invalidate on a break below the trend-line support.
2. Treat a 50-EMA rejection and extension-area arrival as a support-search context, and measure whether a later doji-plus-reversal-bar sequence predicts a reclaim versus continuation lower.
3. Add one-minute bar data, support/resistance reconstruction, option quotes, and outcomes before determining whether any observed reversal sequence was actionable or executable.

## Decision

No live entry, exit, stop, sizing, direction, or other trading-policy change is authorized. This remains research-only: the transcript supports candidate structure labels but leaves synchronized price, option-risk, and outcome evidence incomplete.